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Background
Based on the recent update (November 2009) of the
European AIDS Clinical Society (EACS) guidelines for
HIV-1-infected patients, initiation of antiretroviral ther-
apy (ART) is now also recommended in patients with
350 to 500 CD4+ T cells/µl and additional risk factors.
Methods
In this single-center audit all ART-naïve HIV-1-infected
subjects were screened for their eligibility to start ART
based on CDC stage of disease, CD4+ T cell count and
EACS-defined risk factors to assess the impact of imple-
menting the new recommendations on clinical practice.
Results
In January 2010, 155 out of a total of 994 HIV-1-
infected subjects (16%) under regular observation at the
HIV outpatient clinic of the Vienna General Hospital
were ART-naïve.
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defined risk factor. Immediate initiation of ART was
indicated in 10 subjects with symptomatic HIV-disease
(6.5%). Of the remaining 145 asymptomatic patients, 15
(10.3%) had two consecutive CD4+ T cell counts < 350/
µl and 19 subjects (13.1%) with a CD4+ T cell count
350-500/µl had ≥ 1 EACS-defined risk factor. Of the lat-
ter 19 subjects, six had HBV and/or HCV co-infection
and one patient was suffering from HIV-associated
nephropathy, whereas the remaining 12 subjects had
other risk factors, e.g. age > 50 years, HIV-1 RNA level
> 100000 copies/ml and/or CD4+ T cell decline > 100/
µl within 1 year. Thus, according to the current EACS
guidelines initiation of ART was recommended in 20%
(31/155) and should be considered in additional 8% (12/
155) of treatment-naïve patients. In contrast, treatment
would have been recommended in only 16% of patients
(25/155) based on the previous version of the EACS
guidelines.
Conclusions
In this clinical audit more than 1/4 of all treatment-
naïve patients were eligible for the initiation of ART
based on the updated EACS guidelines representing an
increase of 76% over previous recommendations due to
the inclusion of patients so far not considered eligible.
Unless further studies show that ART initiation would
be beneficial in all patients with a CD4+ T cell count
<500/µl, awareness for HIV-associated and non HIV-
risk factors needs to be increased to identify patients for
whom treatment is recommended.
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